Novel Variants in MDC1 are Associated With Severe Oligoasthenoteratozoospermia
Clinical Genetics · 2026
DOI: 10.1111/cge.70058 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, 2026. Verfasst von Xu Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, Chin…. Hauptthemen laut MEDLINE: Oligospermia, Cell Cycle Proteins, Asthenozoospermia, Genetic Predisposition to Disease. Die Arbeit nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research Program of Anhui Science and Technology Innovation Platform, University Natural Foundation of Anhui Educational Committee.
Abstract (Originalsprache)
Mediator of DNA damage checkpoint 1 (MDC1) is a protein closely associated with the repair of DNA damage. Recently, we identified three novel variants (NM_014641.3:c. C5977T ; p. R1993X ) (NM_014641.3:c. C5644T ; p. R1882X ; c. A1T ; p. M1L ) in MDC1 in two patients with severe oligoasthenoteratozoospermia ( OAT ). In vitro validation showed that the p. R1882X variant resulted in the truncation of the MDC1 protein, and the p. R1993X variant resulted in the degradation of the MDC1 protein after truncation. Immunofluorescence demonstrated that the truncated protein caused by the variants affected the colocalization relationship between MDC1 and its interacting protein γH2AX . Additionally, one of the patients and his wife underwent intracytoplasmic sperm injection ( ICSI ), but the result was unsatisfactory. We screened out the variants of MDC1 in patients with OAT for the first time, and this research could afford precise genetic diagnosis for the patients. It has broadened the variant spectrum of MDC1 , which is conducive to the development of targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), Hefei, Anhui, China.
- Engineering Research Center of Biopreservation and Artificial Organs, Ministry of Education, Hefei, Anhui, China.
- Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, Hefei, Anhui, China.
- Anhui Province Key Laboratory of Reproductive Disorders and Obstetrics and Gynaecology Diseases, Hefei, Anhui, China.
- Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Fuxi Zhu
Förderung
- National Natural Science Foundation of China
- Key Research Program of Anhui Science and Technology Innovation Platform
- University Natural Foundation of Anhui Educational Committee
- Scientific Research Platform Base Construction Foundation of Anhui Medical University
Zitieren
APA
Liu, X., Wang, Y., Tan, C., Tan, H., Wang, W., Hu, P., Cao, Y., Wang, F., Lu, Y., & Zhu, F. (2026). Novel Variants in MDC1 are Associated With Severe Oligoasthenoteratozoospermia. Clinical Genetics. https://doi.org/10.1111/cge.70058
Vancouver
Liu X, Wang Y, Tan C, Tan H, Wang W, Hu P, et al. Novel Variants in MDC1 are Associated With Severe Oligoasthenoteratozoospermia. Clinical Genetics. 2026. doi:10.1111/cge.70058
BibTeX
@article{Liu2026,
author = {Liu, Xu and Wang, Yu and Tan, Chen and Tan, Hujia and Wang, Wenjun and Hu, Pengcheng and Cao, Yunxia and Wang, Fengsong and Lu, Yichang and Zhu, Fuxi},
title = {Novel Variants in MDC1 are Associated With Severe Oligoasthenoteratozoospermia},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70058}
}
EUVIMED